nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—superior mesenteric artery—liver cancer	0.25	0.906	CbGeAlD
Nabumetone—Interstitial pneumonia—Sorafenib—liver cancer	0.0118	0.0306	CcSEcCtD
Nabumetone—Nephrotic syndrome—Sorafenib—liver cancer	0.0118	0.0306	CcSEcCtD
Nabumetone—PTGS2—gall bladder—liver cancer	0.00889	0.0322	CbGeAlD
Nabumetone—Interstitial lung disease—Sorafenib—liver cancer	0.00806	0.0209	CcSEcCtD
Nabumetone—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00745	0.0193	CcSEcCtD
Nabumetone—Glossitis—Sorafenib—liver cancer	0.00619	0.016	CcSEcCtD
Nabumetone—MPO—liver—liver cancer	0.00575	0.0208	CbGeAlD
Nabumetone—PTGS2—embryo—liver cancer	0.00563	0.0204	CbGeAlD
Nabumetone—Bullous eruption—Epirubicin—liver cancer	0.00534	0.0138	CcSEcCtD
Nabumetone—Bullous eruption—Doxorubicin—liver cancer	0.00494	0.0128	CcSEcCtD
Nabumetone—Hepatic failure—Sorafenib—liver cancer	0.00461	0.0119	CcSEcCtD
Nabumetone—Hypokalaemia—Sorafenib—liver cancer	0.00377	0.00976	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00373	0.00965	CcSEcCtD
Nabumetone—Gastritis—Sorafenib—liver cancer	0.00367	0.00949	CcSEcCtD
Nabumetone—Gastric ulcer—Epirubicin—liver cancer	0.00363	0.00939	CcSEcCtD
Nabumetone—Dysphagia—Sorafenib—liver cancer	0.00358	0.00927	CcSEcCtD
Nabumetone—Pancreatitis—Sorafenib—liver cancer	0.00351	0.00908	CcSEcCtD
Nabumetone—Gastric ulcer—Doxorubicin—liver cancer	0.00336	0.00869	CcSEcCtD
Nabumetone—Erectile dysfunction—Sorafenib—liver cancer	0.0033	0.00853	CcSEcCtD
Nabumetone—Weight decreased—Sorafenib—liver cancer	0.00324	0.00838	CcSEcCtD
Nabumetone—Pneumonia—Sorafenib—liver cancer	0.00321	0.00831	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00316	0.00819	CcSEcCtD
Nabumetone—Acute coronary syndrome—Sorafenib—liver cancer	0.00315	0.00814	CcSEcCtD
Nabumetone—CYP1A2—liver—liver cancer	0.00315	0.0114	CbGeAlD
Nabumetone—Renal failure—Sorafenib—liver cancer	0.00314	0.00812	CcSEcCtD
Nabumetone—Myocardial infarction—Sorafenib—liver cancer	0.00313	0.0081	CcSEcCtD
Nabumetone—Jaundice—Sorafenib—liver cancer	0.00311	0.00805	CcSEcCtD
Nabumetone—Stomatitis—Sorafenib—liver cancer	0.00311	0.00805	CcSEcCtD
Nabumetone—Melatonin—ESR1—liver cancer	0.00289	0.432	CrCbGaD
Nabumetone—Haemoglobin—Sorafenib—liver cancer	0.00288	0.00745	CcSEcCtD
Nabumetone—Haemorrhage—Sorafenib—liver cancer	0.00287	0.00742	CcSEcCtD
Nabumetone—Vaginal haemorrhage—Epirubicin—liver cancer	0.00285	0.00737	CcSEcCtD
Nabumetone—Albuminuria—Epirubicin—liver cancer	0.00282	0.00731	CcSEcCtD
Nabumetone—Erythema multiforme—Sorafenib—liver cancer	0.00271	0.00701	CcSEcCtD
Nabumetone—Gingivitis—Epirubicin—liver cancer	0.00269	0.00695	CcSEcCtD
Nabumetone—Tinnitus—Sorafenib—liver cancer	0.00267	0.00691	CcSEcCtD
Nabumetone—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00264	0.00682	CcSEcCtD
Nabumetone—Albuminuria—Doxorubicin—liver cancer	0.00261	0.00676	CcSEcCtD
Nabumetone—PTGS2—liver—liver cancer	0.00261	0.00944	CbGeAlD
Nabumetone—Arrhythmia—Sorafenib—liver cancer	0.00256	0.00663	CcSEcCtD
Nabumetone—Alopecia—Sorafenib—liver cancer	0.00253	0.00655	CcSEcCtD
Nabumetone—Gingivitis—Doxorubicin—liver cancer	0.00249	0.00643	CcSEcCtD
Nabumetone—Jaundice cholestatic—Epirubicin—liver cancer	0.0024	0.00621	CcSEcCtD
Nabumetone—Rectal haemorrhage—Epirubicin—liver cancer	0.00233	0.00604	CcSEcCtD
Nabumetone—Melatonin—CYP1A1—liver cancer	0.00231	0.345	CrCbGaD
Nabumetone—Anaemia—Sorafenib—liver cancer	0.00231	0.00597	CcSEcCtD
Nabumetone—Glossitis—Epirubicin—liver cancer	0.00229	0.00592	CcSEcCtD
Nabumetone—Angioedema—Sorafenib—liver cancer	0.00228	0.0059	CcSEcCtD
Nabumetone—Hyperuricaemia—Epirubicin—liver cancer	0.00227	0.00588	CcSEcCtD
Nabumetone—Syncope—Sorafenib—liver cancer	0.00224	0.00579	CcSEcCtD
Nabumetone—Leukopenia—Sorafenib—liver cancer	0.00223	0.00578	CcSEcCtD
Nabumetone—Jaundice cholestatic—Doxorubicin—liver cancer	0.00222	0.00575	CcSEcCtD
Nabumetone—Loss of consciousness—Sorafenib—liver cancer	0.00219	0.00567	CcSEcCtD
Nabumetone—Cough—Sorafenib—liver cancer	0.00218	0.00563	CcSEcCtD
Nabumetone—Rectal haemorrhage—Doxorubicin—liver cancer	0.00216	0.00559	CcSEcCtD
Nabumetone—Hypertension—Sorafenib—liver cancer	0.00215	0.00557	CcSEcCtD
Nabumetone—Blood uric acid increased—Epirubicin—liver cancer	0.00215	0.00556	CcSEcCtD
Nabumetone—Glossitis—Doxorubicin—liver cancer	0.00212	0.00548	CcSEcCtD
Nabumetone—Hyperuricaemia—Doxorubicin—liver cancer	0.0021	0.00544	CcSEcCtD
Nabumetone—Dry mouth—Sorafenib—liver cancer	0.00208	0.00538	CcSEcCtD
Nabumetone—Eructation—Epirubicin—liver cancer	0.00207	0.00536	CcSEcCtD
Nabumetone—Melaena—Epirubicin—liver cancer	0.00206	0.00533	CcSEcCtD
Nabumetone—Anaphylactic shock—Sorafenib—liver cancer	0.00204	0.00527	CcSEcCtD
Nabumetone—Shock—Sorafenib—liver cancer	0.002	0.00518	CcSEcCtD
Nabumetone—Thrombocytopenia—Sorafenib—liver cancer	0.00199	0.00516	CcSEcCtD
Nabumetone—Blood uric acid increased—Doxorubicin—liver cancer	0.00199	0.00514	CcSEcCtD
Nabumetone—Aplastic anaemia—Epirubicin—liver cancer	0.00198	0.00512	CcSEcCtD
Nabumetone—Anorexia—Sorafenib—liver cancer	0.00194	0.00502	CcSEcCtD
Nabumetone—Eructation—Doxorubicin—liver cancer	0.00192	0.00496	CcSEcCtD
Nabumetone—Melaena—Doxorubicin—liver cancer	0.00191	0.00493	CcSEcCtD
Nabumetone—Abnormal vision—Epirubicin—liver cancer	0.00184	0.00476	CcSEcCtD
Nabumetone—Aplastic anaemia—Doxorubicin—liver cancer	0.00183	0.00474	CcSEcCtD
Nabumetone—Dyspnoea—Sorafenib—liver cancer	0.00182	0.0047	CcSEcCtD
Nabumetone—Dyspepsia—Sorafenib—liver cancer	0.00179	0.00464	CcSEcCtD
Nabumetone—Decreased appetite—Sorafenib—liver cancer	0.00177	0.00458	CcSEcCtD
Nabumetone—Thrombophlebitis—Epirubicin—liver cancer	0.00177	0.00458	CcSEcCtD
Nabumetone—Fatigue—Sorafenib—liver cancer	0.00176	0.00454	CcSEcCtD
Nabumetone—Photosensitivity—Epirubicin—liver cancer	0.00174	0.00451	CcSEcCtD
Nabumetone—Constipation—Sorafenib—liver cancer	0.00174	0.00451	CcSEcCtD
Nabumetone—Hepatic failure—Epirubicin—liver cancer	0.0017	0.00441	CcSEcCtD
Nabumetone—Abnormal vision—Doxorubicin—liver cancer	0.0017	0.0044	CcSEcCtD
Nabumetone—Gastrointestinal pain—Sorafenib—liver cancer	0.00166	0.00431	CcSEcCtD
Nabumetone—Thrombophlebitis—Doxorubicin—liver cancer	0.00164	0.00423	CcSEcCtD
Nabumetone—Increased appetite—Epirubicin—liver cancer	0.00163	0.00422	CcSEcCtD
Nabumetone—Urticaria—Sorafenib—liver cancer	0.00162	0.00419	CcSEcCtD
Nabumetone—Photosensitivity—Doxorubicin—liver cancer	0.00161	0.00417	CcSEcCtD
Nabumetone—Abdominal pain—Sorafenib—liver cancer	0.00161	0.00417	CcSEcCtD
Nabumetone—Body temperature increased—Sorafenib—liver cancer	0.00161	0.00417	CcSEcCtD
Nabumetone—Dermatitis bullous—Epirubicin—liver cancer	0.0016	0.00415	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Epirubicin—liver cancer	0.00158	0.00409	CcSEcCtD
Nabumetone—Hepatic failure—Doxorubicin—liver cancer	0.00158	0.00408	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00153	0.00396	CcSEcCtD
Nabumetone—Increased appetite—Doxorubicin—liver cancer	0.00151	0.0039	CcSEcCtD
Nabumetone—Hypersensitivity—Sorafenib—liver cancer	0.0015	0.00388	CcSEcCtD
Nabumetone—Naproxen—ALB—liver cancer	0.00149	0.223	CrCbGaD
Nabumetone—Dermatitis bullous—Doxorubicin—liver cancer	0.00148	0.00384	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00146	0.00379	CcSEcCtD
Nabumetone—Asthenia—Sorafenib—liver cancer	0.00146	0.00378	CcSEcCtD
Nabumetone—Pruritus—Sorafenib—liver cancer	0.00144	0.00373	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00142	0.00367	CcSEcCtD
Nabumetone—Liver function test abnormal—Epirubicin—liver cancer	0.00141	0.00366	CcSEcCtD
Nabumetone—Hypokalaemia—Epirubicin—liver cancer	0.00139	0.00361	CcSEcCtD
Nabumetone—Diarrhoea—Sorafenib—liver cancer	0.00139	0.00361	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00138	0.00357	CcSEcCtD
Nabumetone—Gastritis—Epirubicin—liver cancer	0.00135	0.00351	CcSEcCtD
Nabumetone—Dizziness—Sorafenib—liver cancer	0.00135	0.00348	CcSEcCtD
Nabumetone—Dysphagia—Epirubicin—liver cancer	0.00132	0.00342	CcSEcCtD
Nabumetone—Asthma—Epirubicin—liver cancer	0.00132	0.00342	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—liver cancer	0.00131	0.00338	CcSEcCtD
Nabumetone—Pancreatitis—Epirubicin—liver cancer	0.0013	0.00336	CcSEcCtD
Nabumetone—Vomiting—Sorafenib—liver cancer	0.00129	0.00335	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—liver cancer	0.00129	0.00334	CcSEcCtD
Nabumetone—Angina pectoris—Epirubicin—liver cancer	0.00129	0.00334	CcSEcCtD
Nabumetone—Rash—Sorafenib—liver cancer	0.00128	0.00332	CcSEcCtD
Nabumetone—Dermatitis—Sorafenib—liver cancer	0.00128	0.00332	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00128	0.0033	CcSEcCtD
Nabumetone—Headache—Sorafenib—liver cancer	0.00128	0.0033	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—liver cancer	0.00125	0.00324	CcSEcCtD
Nabumetone—Dysuria—Epirubicin—liver cancer	0.00124	0.0032	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—liver cancer	0.00122	0.00317	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—liver cancer	0.00122	0.00317	CcSEcCtD
Nabumetone—Nausea—Sorafenib—liver cancer	0.00121	0.00313	CcSEcCtD
Nabumetone—Photosensitivity reaction—Epirubicin—liver cancer	0.00121	0.00313	CcSEcCtD
Nabumetone—Weight increased—Epirubicin—liver cancer	0.0012	0.00312	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—liver cancer	0.0012	0.00311	CcSEcCtD
Nabumetone—Weight decreased—Epirubicin—liver cancer	0.0012	0.0031	CcSEcCtD
Nabumetone—Hyperglycaemia—Epirubicin—liver cancer	0.00119	0.00309	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—liver cancer	0.00119	0.00309	CcSEcCtD
Nabumetone—Pneumonia—Epirubicin—liver cancer	0.00119	0.00307	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00117	0.00303	CcSEcCtD
Nabumetone—Renal failure—Epirubicin—liver cancer	0.00116	0.003	CcSEcCtD
Nabumetone—Stomatitis—Epirubicin—liver cancer	0.00115	0.00298	CcSEcCtD
Nabumetone—Jaundice—Epirubicin—liver cancer	0.00115	0.00298	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—liver cancer	0.00114	0.00296	CcSEcCtD
Nabumetone—Haematuria—Epirubicin—liver cancer	0.00112	0.00291	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—liver cancer	0.00112	0.00289	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—liver cancer	0.00111	0.00288	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—liver cancer	0.00111	0.00287	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—liver cancer	0.0011	0.00286	CcSEcCtD
Nabumetone—Agranulocytosis—Epirubicin—liver cancer	0.0011	0.00285	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—liver cancer	0.0011	0.00284	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00108	0.0028	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—liver cancer	0.00107	0.00278	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—liver cancer	0.00106	0.00275	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—liver cancer	0.00106	0.00275	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—liver cancer	0.00106	0.00275	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—liver cancer	0.00106	0.00274	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—liver cancer	0.00104	0.00269	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—liver cancer	0.00102	0.00264	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—liver cancer	0.00102	0.00264	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—liver cancer	0.001	0.00259	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—liver cancer	0.000987	0.00256	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—liver cancer	0.000985	0.00255	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—liver cancer	0.00098	0.00254	CcSEcCtD
Nabumetone—Chills—Epirubicin—liver cancer	0.00095	0.00246	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—liver cancer	0.000946	0.00245	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—liver cancer	0.000944	0.00244	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—liver cancer	0.000936	0.00242	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—liver cancer	0.000927	0.0024	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—liver cancer	0.000914	0.00236	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—liver cancer	0.000909	0.00235	CcSEcCtD
Nabumetone—Tension—Epirubicin—liver cancer	0.000905	0.00234	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—liver cancer	0.000895	0.00232	CcSEcCtD
Nabumetone—Chills—Doxorubicin—liver cancer	0.000879	0.00228	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—liver cancer	0.000875	0.00227	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—liver cancer	0.000866	0.00224	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—liver cancer	0.000855	0.00221	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—liver cancer	0.000852	0.00221	CcSEcCtD
Nabumetone—Agitation—Epirubicin—liver cancer	0.000847	0.00219	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—liver cancer	0.000841	0.00218	CcSEcCtD
Nabumetone—Tension—Doxorubicin—liver cancer	0.000837	0.00217	CcSEcCtD
Nabumetone—Malaise—Epirubicin—liver cancer	0.000831	0.00215	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—liver cancer	0.000829	0.00214	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—liver cancer	0.000828	0.00214	CcSEcCtD
Nabumetone—Syncope—Epirubicin—liver cancer	0.000827	0.00214	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—liver cancer	0.000825	0.00214	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—liver cancer	0.000815	0.00211	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—liver cancer	0.00081	0.0021	CcSEcCtD
Nabumetone—Cough—Epirubicin—liver cancer	0.000805	0.00208	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—liver cancer	0.000796	0.00206	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—liver cancer	0.000792	0.00205	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—liver cancer	0.000788	0.00204	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—liver cancer	0.000784	0.00203	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—liver cancer	0.000782	0.00202	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—liver cancer	0.000776	0.00201	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—liver cancer	0.000769	0.00199	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—liver cancer	0.000768	0.00199	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—liver cancer	0.000766	0.00198	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—liver cancer	0.000765	0.00198	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—liver cancer	0.000764	0.00198	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—liver cancer	0.000759	0.00196	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—liver cancer	0.000754	0.00195	CcSEcCtD
Nabumetone—Oedema—Epirubicin—liver cancer	0.000752	0.00195	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—liver cancer	0.000752	0.00195	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—liver cancer	0.00075	0.00194	CcSEcCtD
Nabumetone—Cough—Doxorubicin—liver cancer	0.000744	0.00193	CcSEcCtD
Nabumetone—Shock—Epirubicin—liver cancer	0.00074	0.00192	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—liver cancer	0.000737	0.00191	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—liver cancer	0.000737	0.00191	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—liver cancer	0.000727	0.00188	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—liver cancer	0.000724	0.00187	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—liver cancer	0.000718	0.00186	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—liver cancer	0.000717	0.00186	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—liver cancer	0.00071	0.00184	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—liver cancer	0.000702	0.00182	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—liver cancer	0.000696	0.0018	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—liver cancer	0.000696	0.0018	CcSEcCtD
Nabumetone—Shock—Doxorubicin—liver cancer	0.000685	0.00177	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—liver cancer	0.000682	0.00176	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—liver cancer	0.000681	0.00176	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—liver cancer	0.000676	0.00175	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—liver cancer	0.000673	0.00174	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—liver cancer	0.000671	0.00174	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—liver cancer	0.000669	0.00173	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—liver cancer	0.000664	0.00172	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—liver cancer	0.000662	0.00171	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—liver cancer	0.000654	0.00169	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—liver cancer	0.000649	0.00168	CcSEcCtD
Nabumetone—Constipation—Epirubicin—liver cancer	0.000643	0.00167	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—liver cancer	0.00063	0.00163	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—liver cancer	0.000625	0.00162	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—liver cancer	0.000621	0.00161	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—liver cancer	0.00062	0.0016	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—liver cancer	0.000619	0.0016	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—liver cancer	0.000615	0.00159	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—liver cancer	0.000613	0.00159	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—liver cancer	0.000605	0.00157	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—liver cancer	0.0006	0.00155	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—liver cancer	0.000598	0.00155	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—liver cancer	0.000595	0.00154	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—liver cancer	0.000595	0.00154	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—liver cancer	0.000595	0.00154	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—liver cancer	0.000574	0.00148	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000569	0.00147	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—liver cancer	0.000554	0.00143	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—liver cancer	0.000553	0.00143	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—liver cancer	0.00055	0.00142	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—liver cancer	0.00055	0.00142	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—liver cancer	0.00054	0.0014	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—liver cancer	0.000532	0.00138	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—liver cancer	0.000515	0.00133	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—liver cancer	0.000513	0.00133	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—liver cancer	0.0005	0.00129	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—liver cancer	0.000498	0.00129	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—liver cancer	0.000493	0.00127	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—liver cancer	0.000478	0.00124	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—liver cancer	0.000476	0.00123	CcSEcCtD
Nabumetone—Rash—Epirubicin—liver cancer	0.000474	0.00123	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—liver cancer	0.000474	0.00123	CcSEcCtD
Nabumetone—Headache—Epirubicin—liver cancer	0.000471	0.00122	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—liver cancer	0.00046	0.00119	CcSEcCtD
Nabumetone—Nausea—Epirubicin—liver cancer	0.000447	0.00116	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—liver cancer	0.000443	0.00115	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.00044	0.00133	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.00044	0.00133	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00044	0.00133	CbGpPWpGaD
Nabumetone—Rash—Doxorubicin—liver cancer	0.000439	0.00114	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—liver cancer	0.000439	0.00113	CcSEcCtD
Nabumetone—Headache—Doxorubicin—liver cancer	0.000436	0.00113	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000435	0.00131	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—NAT2—liver cancer	0.00043	0.0013	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000424	0.00128	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000414	0.00125	CbGpPWpGaD
Nabumetone—Nausea—Doxorubicin—liver cancer	0.000414	0.00107	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—ALB—liver cancer	0.000413	0.00125	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00041	0.00124	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000407	0.00123	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN2A—liver cancer	0.000402	0.00121	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000395	0.00119	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—liver cancer	0.000384	0.00116	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000379	0.00115	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000367	0.00111	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000363	0.0011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000362	0.00109	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000361	0.00109	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN1B—liver cancer	0.000356	0.00107	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000356	0.00107	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000349	0.00106	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000346	0.00105	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000344	0.00104	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.000339	0.00103	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000336	0.00102	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—UGDH—liver cancer	0.000335	0.00101	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.000328	0.000992	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000326	0.000985	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000326	0.000985	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000319	0.000964	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000318	0.000961	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—EPT1—liver cancer	0.000315	0.000953	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000315	0.000952	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.00031	0.000937	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—liver cancer	0.000308	0.00093	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000301	0.000909	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TAT—liver cancer	0.000299	0.000903	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000294	0.000888	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.00028	0.000847	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000276	0.000836	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000276	0.000835	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000272	0.000822	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000271	0.00082	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000271	0.000819	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000271	0.000819	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000267	0.000807	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—UGDH—liver cancer	0.000266	0.000804	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000266	0.000803	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000265	0.000801	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000258	0.000781	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000257	0.000778	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000256	0.000775	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000251	0.00076	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000251	0.000759	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EPT1—liver cancer	0.00025	0.000756	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000249	0.000753	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000249	0.000752	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000248	0.00075	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000244	0.000738	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TAT—liver cancer	0.000237	0.000717	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000233	0.000705	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000232	0.000702	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000232	0.000702	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000231	0.000699	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.00023	0.000696	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000228	0.000689	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00022	0.000665	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000214	0.000646	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000212	0.000642	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000209	0.000633	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000207	0.000627	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000207	0.000625	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000205	0.000619	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GLUL—liver cancer	0.000203	0.000614	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CPT1B—liver cancer	0.000203	0.000614	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000201	0.000609	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000201	0.000608	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000199	0.0006	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000198	0.000597	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000197	0.000596	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NR1H4—liver cancer	0.000196	0.000592	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000196	0.000592	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000193	0.000584	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA3—liver cancer	0.000193	0.000582	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LTF—liver cancer	0.000193	0.000582	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000184	0.000557	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000181	0.000546	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA4—liver cancer	0.000176	0.000532	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000176	0.000531	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000175	0.00053	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000175	0.000528	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000174	0.000526	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000172	0.00052	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA2—liver cancer	0.000172	0.000519	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.00017	0.000515	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00017	0.000514	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000166	0.000502	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA1—liver cancer	0.000166	0.0005	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NAT2—liver cancer	0.000164	0.000495	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GLUL—liver cancer	0.000161	0.000487	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CPT1B—liver cancer	0.000161	0.000487	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000157	0.000476	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDOB—liver cancer	0.000157	0.000474	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000156	0.000471	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NR1H4—liver cancer	0.000155	0.00047	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000153	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA3—liver cancer	0.000153	0.000462	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000151	0.000457	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UGDH—liver cancer	0.000151	0.000455	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CRABP1—liver cancer	0.00015	0.000453	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ALDOB—liver cancer	0.000149	0.00045	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EPT1—liver cancer	0.000142	0.000428	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000141	0.000426	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000141	0.000425	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA4—liver cancer	0.00014	0.000423	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000137	0.000413	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA2—liver cancer	0.000136	0.000412	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000135	0.000408	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TAT—liver cancer	0.000134	0.000406	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000132	0.000399	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA1—liver cancer	0.000131	0.000397	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000131	0.000397	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HPGDS—liver cancer	0.000131	0.000396	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.00013	0.000394	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.00013	0.000393	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NAT2—liver cancer	0.00013	0.000393	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000125	0.000378	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDOB—liver cancer	0.000125	0.000377	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.00012	0.000362	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CRABP1—liver cancer	0.000119	0.000359	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000119	0.000358	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADAM17—liver cancer	0.000118	0.000356	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000117	0.000354	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PSMA4—liver cancer	0.000117	0.000353	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PSMD10—liver cancer	0.000117	0.000353	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000116	0.00035	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT2—liver cancer	0.000113	0.000343	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSMA4—liver cancer	0.000111	0.000334	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSMD10—liver cancer	0.000111	0.000334	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT2—liver cancer	0.000108	0.000325	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000107	0.000324	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2E1—liver cancer	0.000107	0.000323	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HPGDS—liver cancer	0.000104	0.000314	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000103	0.000312	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000103	0.000312	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYCS—liver cancer	9.98e-05	0.000302	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.88e-05	0.000299	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GGT1—liver cancer	9.8e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT1—liver cancer	9.8e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.78e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.41e-05	0.000284	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.29e-05	0.000281	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT1—liver cancer	9.29e-05	0.000281	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PSMA4—liver cancer	9.26e-05	0.00028	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PSMD10—liver cancer	9.26e-05	0.00028	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GLUL—liver cancer	9.12e-05	0.000276	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CPT1B—liver cancer	9.12e-05	0.000276	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT2—liver cancer	9.01e-05	0.000272	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—liver cancer	8.8e-05	0.000266	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NR1H4—liver cancer	8.8e-05	0.000266	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—liver cancer	8.68e-05	0.000262	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA3—liver cancer	8.65e-05	0.000261	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCE—liver cancer	8.57e-05	0.000259	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2E1—liver cancer	8.47e-05	0.000256	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.2e-05	0.000248	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—liver cancer	8.09e-05	0.000244	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYCS—liver cancer	7.92e-05	0.00024	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA4—liver cancer	7.91e-05	0.000239	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT1—liver cancer	7.78e-05	0.000235	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GGT1—liver cancer	7.78e-05	0.000235	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.73e-05	0.000234	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA2—liver cancer	7.71e-05	0.000233	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1A1—liver cancer	7.67e-05	0.000232	CbGpPWpGaD
Nabumetone—PTGS2—Disease—H2AFX—liver cancer	7.47e-05	0.000226	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA1—liver cancer	7.44e-05	0.000225	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAT2—liver cancer	7.35e-05	0.000222	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—liver cancer	7.15e-05	0.000216	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.07e-05	0.000214	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOB—liver cancer	7.05e-05	0.000213	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARA—liver cancer	7.01e-05	0.000212	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—liver cancer	6.99e-05	0.000211	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—liver cancer	6.89e-05	0.000208	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—liver cancer	6.77e-05	0.000205	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TERT—liver cancer	6.75e-05	0.000204	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CRABP1—liver cancer	6.73e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—liver cancer	6.42e-05	0.000194	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.3e-05	0.00019	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1A1—liver cancer	6.09e-05	0.000184	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.06e-05	0.000183	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—liver cancer	6e-05	0.000181	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPGDS—liver cancer	5.88e-05	0.000178	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.85e-05	0.000177	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—liver cancer	5.79e-05	0.000175	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—liver cancer	5.69e-05	0.000172	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—liver cancer	5.67e-05	0.000171	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARA—liver cancer	5.57e-05	0.000168	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BRAF—liver cancer	5.35e-05	0.000162	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.32e-05	0.000161	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CD—liver cancer	5.28e-05	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.26e-05	0.000159	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PSMA4—liver cancer	5.24e-05	0.000158	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PSMD10—liver cancer	5.24e-05	0.000158	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—liver cancer	5.21e-05	0.000158	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT2—liver cancer	5.1e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CD—liver cancer	5e-05	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5e-05	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—liver cancer	4.95e-05	0.00015	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2E1—liver cancer	4.79e-05	0.000145	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—liver cancer	4.77e-05	0.000144	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.64e-05	0.00014	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CB—liver cancer	4.6e-05	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—liver cancer	4.6e-05	0.000139	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYCS—liver cancer	4.48e-05	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RAF1—liver cancer	4.47e-05	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT1—liver cancer	4.4e-05	0.000133	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GGT1—liver cancer	4.4e-05	0.000133	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CB—liver cancer	4.36e-05	0.000132	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTOR—liver cancer	4.36e-05	0.000132	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CD—liver cancer	4.19e-05	0.000127	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—liver cancer	4.14e-05	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—liver cancer	4.09e-05	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—liver cancer	3.95e-05	0.000119	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—liver cancer	3.9e-05	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CTNNB1—liver cancer	3.87e-05	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—liver cancer	3.78e-05	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CB—liver cancer	3.65e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—liver cancer	3.63e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1A1—liver cancer	3.44e-05	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—liver cancer	3.37e-05	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—liver cancer	3.21e-05	9.7e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARA—liver cancer	3.15e-05	9.52e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—liver cancer	3.13e-05	9.47e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—liver cancer	3.12e-05	9.44e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—liver cancer	2.89e-05	8.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.83e-05	8.55e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—liver cancer	2.8e-05	8.48e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—liver cancer	2.7e-05	8.15e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—liver cancer	2.66e-05	8.04e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—liver cancer	2.6e-05	7.87e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—liver cancer	2.46e-05	7.43e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CD—liver cancer	2.37e-05	7.17e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—liver cancer	2.35e-05	7.12e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—liver cancer	2.34e-05	7.08e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—liver cancer	2.29e-05	6.93e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—liver cancer	2.23e-05	6.73e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—liver cancer	2.17e-05	6.56e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CB—liver cancer	2.07e-05	6.25e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—liver cancer	1.82e-05	5.5e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—liver cancer	1.26e-05	3.81e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—liver cancer	1.03e-05	3.11e-05	CbGpPWpGaD
